Cardiology Fiesta 2017
Avatar

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibition

By Cardiology Fiesta 2017 FEATURING Ralph DeFronzo
By Cardiology Fiesta 2017 FEATURING Ralph DeFronzo
0 views
November 10, 2017
Comments 7
Login to view comments. Click here to Login

Featured Video

48:22
Lilly Diabetes

A Journey Through Clinical Efficacy and Safety Data Comparing Two T2…

Feat. B. Hirsch

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Recommended

AUTOPLAY
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
61:49
Obafemi Awolowo University

Management of Heart Failure

Feat. O. A. Akinyele
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

37:21
University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
19:30
ACC 2022 Conference Coverage

Hot Topics in Heart Failure ACC.22

Feat. N. Ibrahim
14:19
UChicago Medicine

S-QUAD Therapy and Beyond: HFpEF in 2024

Feat. M. Belkin
10:02
Emory Diabetes Education Training Academy

Insulin Treatment in Patients with Type 2 Diabetes: When to Use Comb…

Feat. G. Umpierrez
27:52
Top Ten Topics in Clinical Cardiology 2023

Medical Management of Diastolic Dysfunction: Does The Emperor Finall…

Feat. S. Pinney
13:42
George Bakris

Current Status of Prevention and Treatment of Diabetic Nephropathy

13:43
Stanford Medicine

What's the Ideal Therapy for Obesity?

Feat. A. Yeoh
34:04
The Texas Heart Institute

Use of Finerenone in Patients with Diabetes Who Have Kidney Disease

Feat. G. Bakris
11:50
American Heart & Vascular Institute

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

Feat. M. Kittleson
15:25
Javed Butler

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

22:48
Scripps Health

Heart Failure with Preserved Ejection Fraction: New Treatments

Feat. R. C. Mohan
14:02
Georgia Heart Institute

Heart Failure Therapies

Feat. U. Egolum, H. Samady